Wang et al., 2018 - Google Patents
Regulation of the human placental (pro) renin receptor-prorenin-angiotensin system by microRNAsWang et al., 2018
View HTML- Document ID
- 8745868120806943557
- Author
- Wang Y
- Lumbers E
- Arthurs A
- Corbisier de Meaultsart C
- Mathe A
- Avery-Kiejda K
- Roberts C
- Pipkin F
- Marques F
- Morris B
- Pringle K
- Publication year
- Publication venue
- MHR: Basic science of reproductive medicine
External Links
Snippet
Abstract STUDY QUESTION Are any microRNAs (miRNAs) that target the placental renin- angiotensin system (RAS) in the human placenta suppressed in early gestation? SUMMARY ANSWER Overall, 21 miRNAs with predicted RAS mRNA targets were less abundant in …
- 229920001239 microRNA 0 title abstract description 179
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Regulation of the human placental (pro) renin receptor-prorenin-angiotensin system by microRNAs | |
Than et al. | Integrated systems biology approach identifies novel maternal and placental pathways of preeclampsia | |
Estella et al. | miRNA signature and Dicer requirement during human endometrial stromal decidualization in vitro | |
Lv et al. | Dysregulated pseudogene HK2P1 may contribute to preeclampsia as a competing endogenous RNA for hexokinase 2 by impairing decidualization | |
Su et al. | miR‐346 and miR‐582‐3p‐regulated EG‐VEGF expression and trophoblast invasion via matrix metalloproteinases 2 and 9 | |
Zhou et al. | The aberrantly expressed miR-193b-3p contributes to preeclampsia through regulating transforming growth factor-β signaling | |
Winship et al. | Interleukin-11 alters placentation and causes preeclampsia features in mice | |
Wang et al. | Elevated miR‐200a and miR‐141 inhibit endocrine gland‐derived vascular endothelial growth factor expression and ciliogenesis in preeclampsia | |
Stephen et al. | Transcriptomic profiling of human choriodecidua during term labor: inflammation as a key driver of labor | |
Molinari et al. | Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence | |
Weedon-Fekjær et al. | Placental miR-1301 is dysregulated in early-onset preeclampsia and inversely correlated with maternal circulating leptin | |
Lalevée et al. | miR455 is linked to hypoxia signaling and is deregulated in preeclampsia | |
Xiang et al. | Decreased expression of long non-coding RNA SNHG7 cause recurrent spontaneous abortion through suppression proliferation and invasion of trophoblast cells via miR-34a | |
Schanzenbach et al. | Can milk cell or skim milk miRNAs be used as biomarkers for early pregnancy detection in cattle? | |
Muter et al. | The glycosyltransferase EOGT regulates adropin expression in decidualizing human endometrium | |
Hong et al. | Down-regulation of miR-378a-3p induces decidual cell apoptosis: a possible mechanism for early pregnancy loss | |
Griffiths et al. | miR-29c overexpression and COL4A1 downregulation in infertile human endometrium reduces endometrial epithelial cell adhesive capacity in vitro implying roles in receptivity | |
Pathirage et al. | Homeobox gene transforming growth factor β-induced factor-1 (TGIF-1) is a regulator of villous trophoblast differentiation and its expression is increased in human idiopathic fetal growth restriction | |
Wang et al. | Vitamin D stimulates multiple microRNAs to inhibit CRH and other pro-labor genes in human placenta | |
Arthurs et al. | MicroRNA mimics that target the placental renin–angiotensin system inhibit trophoblast proliferation | |
Visser et al. | The effect of maternal NODAL on STOX1 expression in extravillous trophoblasts is mediated by IGF1 | |
Chen et al. | miR-4443/MMP2 suppresses the migration and invasion of trophoblasts through the HB-EGF/EGFR pathway in preeclampsia | |
Guiyu et al. | LncRNA-SNX17 promotes HTR-8/SVneo proliferation and invasion through miR-517a/IGF-1 in the placenta of diabetic macrosomia | |
Murrieta-Coxca et al. | Identification of altered miRNAs and their targets in placenta accreta | |
Ojeda-Casares et al. | The regulatory network played by miRNAs during normal pregnancy and preeclampsia: a comparative study |